CLINTON CLOUD: Open Payments
NPI 1538793880 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 17 payments from 10 companies in 2025. Trend: 2023 $524 · 2024 $213 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Insmed, Inc. | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| GENZYME CORPORATION | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
Products named: DUPIXENT, Arikayce, FASENRA, JASCAYD, Prolastin-C Liquid, TEZSPIRE, NUCALA, Xolair.
Industry payments across MO — which companies pay providers there.
